Literature DB >> 28024276

Effect of lifestyle interventions on glucose regulation among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.

Xuanping Zhang1, Giuseppina Imperatore2, William Thomas3, Yiling J Cheng4, Felipe Lobelo5, Keri Norris6, Heather M Devlin7, Mohammed K Ali8, Stephanie Gruss9, Barbara Bardenheier10, Pyone Cho11, Isabel Garcia de Quevedo12, Uma Mudaliar13, Jinan Saaddine14, Linda S Geiss15, Edward W Gregg16.   

Abstract

This study systematically assessed the effectiveness of lifestyle interventions on glycemic indicators among adults (⩾18years) without IGT or diabetes. Randomized controlled trials using physical activity (PA), diet (D), or their combined strategies (PA+D) with follow-up ⩾12months were systematically searched from multiple electronic-databases between inception and May 4, 2016. Outcome measures included fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), fasting insulin (FI), homeostasis model assessment-estimated insulin resistance (HOMA-IR), and bodyweight. Included studies were divided into low-range (FPG <5.5mmol/L or HbA1c <5.5%) and high-range (FPG ⩾5.5mmol/L or HbA1c ⩾5.5%) groups according to baseline glycemic levels. Seventy-nine studies met inclusion criteria. Random-effect models demonstrated that compared with usual care, lifestyle interventions achieved significant reductions in FPG (-0.14mmol/L [95%CI, -0.19, -0.10]), HbA1c (-0.06% [-0.09, -0.03]), FI (%change: -15.18% [-20.01, -10.35]), HOMA-IR (%change: -22.82% [-29.14, -16.51]), and bodyweight (%change: -3.99% [-4.69, -3.29]). The same effect sizes in FPG reduction (0.07) appeared among both low-range and high-range groups. Similar effects were observed among all groups regardless of lengths of follow-up. D and PA+D interventions had larger effects on glucose reduction than PA alone. Lifestyle interventions significantly improved FPG, HbA1c, FI, HOMA-IR, and bodyweight among adults without IGT or diabetes, and might reduce progression of hyperglycemia to type 2 diabetes mellitus. Published by Elsevier B.V.

Entities:  

Keywords:  Glucose regulation; Lifestyle intervention; Meta-analysis; Systematic review

Mesh:

Substances:

Year:  2016        PMID: 28024276      PMCID: PMC6625761          DOI: 10.1016/j.diabres.2016.11.020

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  17 in total

1.  Rationale and design of Smart Walk: A randomized controlled pilot trial of a smartphone-delivered physical activity and cardiometabolic risk reduction intervention for African American women.

Authors:  Rodney P Joseph; Barbara E Ainsworth; Sonia Vega-López; Marc A Adams; Kevin Hollingshead; Steven P Hooker; Michael Todd; Glenn A Gaesser; Colleen Keller
Journal:  Contemp Clin Trials       Date:  2018-12-18       Impact factor: 2.226

Review 2.  Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.

Authors:  Bianca Hemmingsen; Gabriel Gimenez-Perez; Didac Mauricio; Marta Roqué I Figuls; Maria-Inti Metzendorf; Bernd Richter
Journal:  Cochrane Database Syst Rev       Date:  2017-12-04

Review 3.  Lifestyle interventions for the prevention and treatment of hypertension.

Authors:  Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia
Journal:  Nat Rev Cardiol       Date:  2020-10-09       Impact factor: 32.419

4.  Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.

Authors:  Linda J Andes; Yiling J Cheng; Deborah B Rolka; Edward W Gregg; Giuseppina Imperatore
Journal:  JAMA Pediatr       Date:  2020-02-03       Impact factor: 16.193

5.  Effects of a Weight Loss Program on Metabolic Syndrome, Eating Disorders and Psychological Outcomes: Mediation by Endocannabinoids?

Authors:  Zoltan Pataky; Isabelle Carrard; Valerie Gay; Aurélien Thomas; Anne Carpentier; Elisabetta Bobbioni-Harsch; Alain Golay
Journal:  Obes Facts       Date:  2018-04-10       Impact factor: 3.942

6.  Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study.

Authors:  Piero Ruscitti; Francesco Ursini; Paola Cipriani; Francesco Ciccia; Vasiliki Liakouli; Francesco Carubbi; Giuliana Guggino; Onorina Berardicurti; Rosadaniela Grembiale; Giovanni Triolo; Giovambattista De Sarro; Roberto Giacomelli
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

Review 7.  Effect of lifestyle interventions on cardiovascular risk factors among adults without impaired glucose tolerance or diabetes: A systematic review and meta-analysis.

Authors:  Xuanping Zhang; Heather M Devlin; Bryce Smith; Giuseppina Imperatore; William Thomas; Felipe Lobelo; Mohammed K Ali; Keri Norris; Stephanie Gruss; Barbara Bardenheier; Pyone Cho; Isabel Garcia de Quevedo; Uma Mudaliar; Christopher D Jones; Jeffrey M Durthaler; Jinan Saaddine; Linda S Geiss; Edward W Gregg
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

8.  Effects of weight loss intervention on body composition and blood pressure among overweight and obese women: findings from the MyBFF@home study.

Authors:  Mansor Fazliana; Ahmad Zamri Liyana; Azahadi Omar; Rashidah Ambak; Noor Safiza Mohamad Nor; Ummi Kalthom Shamsudin; Narul Aida Salleh; Tahir Aris
Journal:  BMC Womens Health       Date:  2018-07-19       Impact factor: 2.809

9.  Effect of Breakfast Consumption and Meal Time Regularity on Nutrient Intake and Cardiometabolic Health in Korean Adults.

Authors:  So Ra Yoon; Miok Choi; Oh Yoen Kim
Journal:  J Lipid Atheroscler       Date:  2021-05-03

Review 10.  Blood Sugar Regulation for Cardiovascular Health Promotion and Disease Prevention: JACC Health Promotion Series.

Authors:  Peter E H Schwarz; Patrick Timpel; Lorenz Harst; Colin J Greaves; Mohammed K Ali; Jeffrey Lambert; Mary Beth Weber; Mohamad M Almedawar; Henning Morawietz
Journal:  J Am Coll Cardiol       Date:  2018-10-09       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.